Gilles Peytavin

32PUBLICATIONS
57CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsPharmacogenomicsRegenerative medicine (incl. stem cells)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 22, 2026
Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program a.

|Jun 22, 2026
Add-on efficacy of doravirine in PLWHIV with virological failure and low-level viremia.

|May 22, 2026
External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

|May 22, 2026
Drug interactions and kidney safety of bictegravir/emtricitabine/tenofovir alafenamide in kidney transplant recipients with HIV: an interventional pilot study.

|Feb 15, 2026
HBV reactivation after switching to cabotegravir plus rilpivirine therapy among people living with HIV: do not forget the reservoir.

Rémi Rouget, Sophie Seang, Marion Favier

|Dec 17, 2025
Maternal-Fetal Letermovir Exposure In Vivo and Physiologically Based Pharmacokinetic Modeling: A Rationale for Congenital Cytomegalovirus Therapy.

Valentine Faure Bardon, Naim Bouazza, Gilles Peytavin

Pageof 6

Frequent Collaborators

12 joint publications

Minh-Patrick Le

5 joint publications

Jade Ghosn

5 joint publications

Quentin Le Hingrat

4 joint publications

Marc Wirden